|
IAC Express 2007 |
| Issue number 688: October 15, 2007 |
| |
Contents
of this Issue
Select a title to jump to the article. |
- October
2007 issue of Needle Tips offers many resources for childhood, adolescent,
and adult immunization
- NFID's
Childhood Influenza Immunization Coalition launches website for patients,
health professionals, and the media
- Looking
for a vaccine-related article? Check out IAC's redesigned journal articles
web section
- IAC
screening questionnaire updated to reflect FDA approval for using LAIV in
children age 2-5 years
- MMWR
announces FDA's March 28 approval of alternative dosing schedule for
Twinrix combined hepatitis A and B vaccine
|
| |
| Abbreviations |
|
|
AAFP, American Academy of Family Physicians; AAP,
American Academy of Pediatrics; ACIP, Advisory Committee on Immunization
Practices; AMA, American Medical Association; CDC, Centers for Disease
Control and Prevention; FDA, Food and Drug Administration; IAC, Immunization
Action Coalition; MMWR, Morbidity and Mortality Weekly Report; NCIRD,
National Center for Immunization and Respiratory Diseases; NIVS, National
Influenza Vaccine Summit; VIS, Vaccine Information Statement; VPD,
vaccine-preventable disease; WHO, World Health Organization. |
| |
|
Issue 688: October 15, 2007 |
|
|
|
1. |
October 2007 issue of Needle Tips offers many resources for childhood,
adolescent, and adult immunization
IAC recently mailed the latest issue of Needle
Tips (October
2007) to 190,000 health professionals and others who work in the
field of immunization. Packed with immunization and hepatitis
resources for health professionals, patients, and parents, the
24-page issue is well worth downloading. All articles and
education pieces, except editorials, have been reviewed by
immunization and hepatitis experts at CDC.
You can view selected articles from the table of contents below
or download the entire issue from the Web.
To download a ready-to-print (PDF) version of the entire issue,
go to: http://www.immunize.org/nslt.d/n37/n37.pdf
The PDF file of the entire issue is large. For tips on
downloading and printing PDF files, go to:
http://www.immunize.org/nslt.d/tips.htm
To view the table of contents with links to individual articles,
go to: http://www.immunize.org/nt
The October issue includes several notable articles, all of
which can be downloaded:
-
Ask the Experts
-
Vaccine Highlights
-
Summary of Recommendations for Childhood and Adolescent
Immunization
-
Summary of Recommendations for Adult Immunization
-
Guidelines for Standing Orders in Labor & Delivery and Nursery
Units to Prevent Hepatitis B Virus (HBV) Transmission to
Newborns
-
Questions Frequently Asked About Hepatitis B, plus four
additional viral hepatitis educational print materials for
patients and staff
-
Screening Questionnaire for Child and Teen Immunization
-
Reliable Sources of Immunization Information: Where to go to
find answers!
-
Give These People Influenza Vaccine!
-
Influenza vaccination standing orders, screening
questionnaires, and other educational print materials for
patients and staff
Back to top |
| |
|
|
2. |
NFID's Childhood Influenza Immunization Coalition launches website for
patients, health professionals, and the media
The National Foundation for Infectious Diseases (NFID)
recently
established the Childhood Influenza Immunization Coalition
(CIIC). Comprising representatives of 25 of the nation's leading
public health, medical, patient, and parent groups committed to
protecting children's health and encouraging wellness, CIIC
seeks to address and improve the low influenza immunization
rates among infants, children, and adolescents.
To that end, CIIC has developed a website of resources for the
public, health professionals, and the media. Resources include
informational materials, personal stories, fact sheets, public
service announcements, and press releases.
A special feature of the CIIC site is the online Influenza Risk
Calculator, located at
http://www.preventchildhoodinfluenza.org/calculator
To access the CIIC website, go to:
http://www.preventchildhoodinfluenza.org
For a listing of the 25 member organizations, go to:
http://www.preventchildhoodinfluenza.org/about/member.php
Back to top |
| |
|
|
3. |
Looking for a vaccine-related article? Check out IAC's redesigned journal
articles web section
IAC recently completed the redesign of its vast
online
collection of links to vaccine-related journal articles. IAC's
selection of practical, clinical, and programmatic articles is
now presented in a well-organized, easy-to-access format.
The section's homepage offers users an alphabetical listing of
18 vaccine-preventable diseases. Click on a disease, and you
will be taken to a chronological catalog of links to recently
published (2004-2007) journal articles pertinent to the disease
or topic. Each article listed offers users a live link to the
article's abstract and/or full text.
Articles published before 2004 are available in archives
organized chronologically by disease.
To access the Vaccine-Related Journal Articles web section, go
to:
http://www.immunize.org/journalarticles
Back to top |
| |
|
|
4. |
IAC screening questionnaire updated to reflect FDA approval for using LAIV in
children age 2-5 years
IAC recently updated its Screening Questionnaire
for Intranasal
Influenza Vaccination. It now reflects the FDA-approved change
in the age at which the live intranasal influenza vaccine (LAIV;
nasal-spray) can be given to children. Previously, LAIV was approved for use in children age 5 years and older; it is now
approved for use in children age 2 years and older.
To access the revised questionnaire, go to:
http://www.immunize.org/catg.d/p4067.pdf
Back to top |
| |
|
|
5. |
MMWR announces FDA's March 28 approval of alternative dosing schedule for
Twinrix combined hepatitis A and B vaccine
CDC published "Notice to Readers: FDA Approval of
an Alternative
Dosing Schedule for a Combined Hepatitis A and B Vaccine
(Twinrix)" in the October 12 issue of MMWR. The notice is
reprinted below in its entirety.
[IAC Express editor's note: FDA approved the alternative
schedule on March 28, 2007. The alternative schedule could
benefit individuals traveling to high-risk areas; emergency
responders, especially those being deployed to disaster areas
overseas; and others who are at risk for hepatitis A and B
infection.]
In April 2007, GlaxoSmithKline Vaccine Division (GlaxoSmithKline
Biologicals, King of Prussia, Pennsylvania) received approval
from the Food and Drug Administration (FDA) for an alternate
schedule for Twinrix, a combined hepatitis A and hepatitis B
vaccine. Twinrix was first licensed by FDA in 2001 on a 3-dose
schedule (0, 1, and 6 months) for vaccination of persons aged >=18 years. Using the newly licensed, alternate 4-dose schedule,
Twinrix doses can be administered at 0, 7, and 21-30 days,
followed by a dose at 12 months.
In immunogenicity studies among adults aged >=18 years, the
first 3 doses of the alternate schedule provided equivalent
protection to the first 2 doses in the standard 3-dose Twinrix
series. The first 3 doses of the alternate schedule also have
proven effective in providing protection equivalent to a single
dose of monovalent hepatitis A vaccine and to 2 doses of
monovalent hepatitis B vaccine, administered using the licensed
schedules for the monovalent vaccines. Thus, the alternate 4-dose schedule can be useful if vaccination with Twinrix has been
initiated and travel or other potential exposure is anticipated
before the second dose of Twinrix (or monovalent hepatitis B
vaccine) is due, according to the standard 3-dose schedule
(i.e., 1 month after the first dose). Additional information is
available from the manufacturer's package insert
[http://www.fda.gov/cber/label/hahbgsk032807lb.pdf] and
GlaxoSmithKline Vaccines, telephone (800) 366-8900.
To access a web-text (HTML) version of the complete article, go
to: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5640a5.htm
To access a ready-to-print (PDF) version of this issue of MMWR,
go to: http://www.cdc.gov/mmwr/PDF/wk/mm5640.pdf
To receive a FREE electronic subscription to MMWR (which
includes new ACIP statements), go to:
http://www.cdc.gov/mmwr/mmwrsubscribe.html
Back to top |
| |
|
|
